APA

Myllykangas-Luosujärvi R., Lu H. S., Chen S. L., Choon D., Amante C., Chow C. T., Pasero G., Genti G., Sarembock B., Zerbini C. A. F., Vrijens F., Moan A., Rodgers D. B., De Tora L. & Laurenzi M. (20030102). Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration. : Scandinavian journal of rheumatology.

Chicago

Myllykangas-Luosujärvi R, Lu H S, Chen S L, Choon D, Amante C, Chow C T, Pasero G, Genti Gy, Sarembock B, Zerbini C A F, Vrijens F, Moan A, Rodgers D B, De Tora L and Laurenzi M. 20030102. Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration. : Scandinavian journal of rheumatology.

Harvard

Myllykangas-Luosujärvi R., Lu H. S., Chen S. L., Choon D., Amante C., Chow C. T., Pasero G., Genti G., Sarembock B., Zerbini C. A. F., Vrijens F., Moan A., Rodgers D. B., De Tora L. and Laurenzi M. (20030102). Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration. : Scandinavian journal of rheumatology.

MLA

Myllykangas-Luosujärvi R, Lu H S, Chen S L, Choon D, Amante C, Chow C T, Pasero G, Genti Gy, Sarembock B, Zerbini C A F, Vrijens F, Moan A, Rodgers D B, De Tora L and Laurenzi M. Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration. : Scandinavian journal of rheumatology. 20030102.